UK Markets close in 1 hr 9 mins

Cara Therapeutics, Inc. (CARA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
12.73-0.07 (-0.55%)
As of 10:21AM EST. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts7767
Avg. Estimate-0.39-0.55-1.96-1.23
Low estimate-0.73-0.67-2.17-1.83
High estimate0-0.35-1.6-0.47
Year ago EPS-0.351.590.18-1.96
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts7667
Avg. Estimate11.78M6.67M20.93M83.75M
Low estimateN/AN/A16.9M45.4M
High estimate25M13.5M26.93M127.61M
Year ago sales9.27M112.09M135.08M20.93M
Sales growth (year/est)27.10%-94.00%-84.50%300.10%
Earnings history29/09/202030/12/202030/03/202129/06/2021
Est. EPS-0.60.36-0.59-0.53
Actual EPS-0.351.59-0.47-0.61
Difference0.251.230.12-0.08
Surprise %41.70%341.70%20.30%-15.10%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate-0.39-0.55-1.96-1.23
7 days ago-0.39-0.55-1.96-1.23
30 days ago-0.36-0.53-1.91-0.84
60 days ago-0.37-0.43-1.7-0.8
90 days ago-0.37-0.43-1.7-0.8
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days3232
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCARAIndustrySector(s)S&P 500
Current qtr.-11.40%N/AN/AN/A
Next qtr.-134.60%N/AN/AN/A
Current year-1,188.90%N/AN/AN/A
Next year37.20%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A